We are live on ! Find out more
CCM

Callodine Capital Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 8.74%
This Fund
S&P 500
This Quarter Est. Return
+19.46%
1 Year Est. Return
+8.74%
3 Year Est. Return
+43.6%
5 Year Est. Return
+40.63%
10 Year Est. Return
–
AUM
$207M
AUM Growth
+$18.8M
Cap. Flow
-$12.6M
Cap. Flow %
-6.11%
Top 10 Hldgs %
53.9%
Holding
45
New
5
Increased
16
Reduced
12
Closed
7

Top Buys

Rank Stock Value
1
ARES icon
Ares Management
ARES
+$6.79M
2
SBH icon
Sally Beauty Holdings
SBH
+$4.61M
3
NEM icon
Newmont
NEM
+$2.31M
4
PNNT
Pennant Park Investment Corp
PNNT
+$1.98M
5
VST icon
Vistra
VST
+$1.96M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$8.87M
2
RDN icon
Radian Group
RDN
+$7.69M
3
VZ icon
Verizon
VZ
+$4.31M
4
CMCSA icon
Comcast
CMCSA
+$3.93M
5
FE icon
FirstEnergy
FE
+$3.59M

Sector Composition

Rank Sector Weight
1 Financials 43.15%
2 Consumer Staples 14.11%
3 Healthcare 13.85%
4 Consumer Discretionary 8.45%
5 Communication Services 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ET icon
26
Energy Transfer Partners
ET
$69.3B
$2.16M 1.05%
350,000
+25,000
+8% +$151K
BCSF icon
27
Bain Capital Specialty
BCSF
$850M
$2.12M 1.03%
175,000
+85,000
+94% +$942K
LPLA icon
28
LPL Financial
LPLA
$28.6B
$2.08M 1.01%
20,000
– –
VST icon
29
Vistra
VST
$47.4B
$2.06M 1%
+105,000
New +$1.96M
OBDC icon
30
Blue Owl Capital
OBDC
$5.74B
$1.9M 0.92%
150,000
+75,000
+100% +$951K
FSKR
31
DELISTED
FS KKR Capital Corp. II
FSKR
$1.89M 0.91%
115,000
+85,000
+283% +$1.36M
BBDC icon
32
Barings BDC
BBDC
$965M
$1.84M 0.89%
200,000
+52,700
+36% +$448K
CCAP icon
33
Crescent Capital BDC
CCAP
$434M
$1.3M 0.63%
+89,266
New +$1.22M
SLRC icon
34
SLR Investment Corp
SLRC
$715M
$1.29M 0.63%
73,957
+43,457
+142% +$737K
MOS icon
35
The Mosaic Company
MOS
$7.33B
$1.15M 0.56%
+50,000
New +$1.01M
OCSL icon
36
Oaktree Specialty Lending
OCSL
$1.14B
$1.11M 0.54%
66,667
+36,667
+122% +$569K
BCIC
37
BCP Investment Corp
BCIC
$92.9M
$1.08M 0.52%
56,718
-55,640
-50% -$838K
CG icon
38
Carlyle Group
CG
$17.2B
$314K 0.15%
+10,000
New +$282K
CMCSA icon
39
Comcast
CMCSA
$90B
– –
-85,000
Closed -$3.93M
FE icon
40
FirstEnergy
FE
$27.5B
– –
-125,000
Closed -$3.59M
SCM icon
41
Stellus Capital Investment Corp
SCM
$243M
– –
-46,313
Closed -$403K
SRCL
42
DELISTED
Stericycle Inc
SRCL
– –
-30,000
Closed -$1.89M
ALXN
43
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-77,500
Closed -$8.87M
HCAP
44
DELISTED
Harvest Capital Credit Corporation
HCAP
– –
-73,696
Closed -$254K
TCP
45
DELISTED
TC Pipelines LP
TCP
– –
-10,000
Closed -$256K
1
2

Similar funds

TS
Triglav Skladi Ljubljana, Slovenia $1.43B AUM 39.24% 1-Year Est. Return
SCA
Stonebridge Capital Advisors St Paul, Minnesota $1.43B AUM 21.98% 1-Year Est. Return
SC
Styrax Capital New York $1.43B AUM 50.63% 1-Year Est. Return
KGI
Kopernik Global Investors Tampa, Florida $1.43B AUM 63.57% 1-Year Est. Return
WIM
Weitz Investment Management Omaha, Nebraska $1.43B AUM 0.51% 1-Year Est. Return
APCM
Alaska Permanent Capital Management Anchorage, Alaska $1.43B AUM 13.12% 1-Year Est. Return
KCMH
Kontiki Capital Management (HK) Hong Kong $1.43B AUM 9.81% 1-Year Est. Return
LCG
Luxor Capital Group New York $1.43B AUM 30.88% 1-Year Est. Return

Callodine Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Callodine Capital Management held 45 positions worth $207M, up 10% from $188M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Callodine Capital Management withdrew a net $12.6M in Q4 2020, closing 7 positions and reducing 12 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $8.87M position sold in full.

By sector, the portfolio is most concentrated in Financials at 43% of assets, up from 37% a quarter earlier, followed by Consumer Staples and Healthcare.

Against the trend, Callodine Capital Management opened a new position in Sally Beauty Holdings worth $5.63M.

  • Callodine Capital Management's largest Q4 2020 buy was Sally Beauty Holdings: 431,514 shares worth $5.63M.
  • Callodine Capital Management added most to Ares Management in Q4 2020, an estimated $6.79M increase.
  • Callodine Capital Management's biggest Q4 2020 reduction was Radian Group, cutting an estimated $7.69M.
  • Callodine Capital Management fully exited Alexion Pharmaceuticals in Q4 2020, selling an estimated $8.87M.
  • Callodine Capital Management's ten largest holdings make up 54% of its $207M portfolio in Q4 2020.
  • Callodine Capital Management opened 5 new positions and closed 7 in Q4 2020.
  • Callodine Capital Management's portfolio value rose 10% quarter-over-quarter to $207M.

Based on Callodine Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.